Ovarian tumours and adnexal masses encompass a broad spectrum of pathologies, ranging from benign cysts to aggressive malignancies. Accurate and early diagnosis is critical due to the high mortality ...

First women’s health test marks a new chapter for InterVenn, providing access to non-invasive testing that differentiates between cancerous and benign pelvic masses for improved treatment planning ...

In a recent paper published in Nature, researchers at the University of Chicago discovered how to block nicotinamide N-methyl transferase (NNMT), an enzyme that is involved in the progression of ...

A panelist discusses how multiple molecular biomarkers beyond BRCA and homologous recombination deficiency (HRD) testing are emerging as important for guiding ovarian cancer therapy, including ...

Ovarian cancer is the eighth most common cancer among women. [1] Owing to the slow progression and initial vague symptoms of the disease, many cases are diagnosed at an advanced stage, when treatments ...

Dr. Lauren Juyia first learned she had cancer last year, when she was just 37. A young Florida doctor who discovered her own cancer last year is opening up about her personal health journey in the ...

When doctors rushed her for a CT scan, it revealed two huge masses on her ovaries — one the size of a football ... Her doctor gave her the thumbs up, and Peoples burst into tears. The tumors had not ...

JSKN003, a biparatopic anti-HER2 antibody drug conjugate (ADC), in the treatment of platinum-resistant ovarian cancer (PROC): Updated findings from two clinical trials. This is an ASCO Meeting ...

Beyond medical interventions, diet and lifestyle significantly enhance ovarian cancer recovery and quality of life. A ...